期刊文献+

转氨酶水平与非酒精性脂肪肝的关系 被引量:16

Relationship between transaminase level and nonalcoholic fatty liver
下载PDF
导出
摘要 目的:探讨非酒精性脂肪肝(NAFLD)的影响因素及转氨酶水平与NAFLD的关系。方法:选取健康体检者3488人,其中NAFLD患者1469例,无NAFLD者2019例,收集一般资料及体格检查、生化指标检测、腹部超声检查的资料,分析NAFLD发生的影响因素。结果:ALT和AST处于正常范围内中位数以上的被检者NAFLD患病率显著高于二者处于中位数及以下者(P<0.001.。NAFLD和无NAFLD者性别、年龄、BMI、谷氨酰转肽酶(GGT)、碱性磷酸酶(ALT)、胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、空腹血糖(FPG)的差异有统计学意义(P均<0.001.。Logistic回归分析显示男性(OR=0.751,95%CI=0.708-0.797)、高BMI(OR=5.738,95%CI=5.412-6.084)、高FPG(OR=2.252,95%CI=2.063-2.459)、高TG(OR=3.036,95%CI=2.851-3.232.、高ALT(OR=2.300,95%CI=2.171-2.437)、高GGT(OR=2.309,95%CI=2.047-2.605)是NAFLD的影响因素。结论:转氨酶水平升高对诊断NAFLD有重要价值,早期采取合理的降低转氨酶水平的措施有可能逆转脂肪肝的发生。 Aim:To investigate the risk factors of non-alcoholic fatty liver disease(NAFLD)and the relationship between transaminase level and NAFLD.Methods:A total of 3488 patients in the physical examination center were included in this study.Physical examination data,laboratory assessments as well as hepatic ultrasound examination results were collected,and the risk factors of NAFLD were analyzed.Results:There was a significant difference in the NAFLD between the ALT and AST of normal high value and low value.The NAFLD group favored male and older,had higher BMI,higher GGT,higher ALP,higher TC,higher TG,lower HDL,higher LDL,higher FPG(P<0.001..Based on logistic regression,male(OR=0.751,95%CI=0.708-0.797),higher BMI(OR=5.738,95%CI=5.412-6.084),higher FPG(OR=2.252,95%CI=2.063-2.459),higher TG(OR=3.036,95%CI=2.851-3.232.,higher ALT(OR=2.300,95%CI=2.171-2.437),higher GGT(OR=2.309,95%CI=2.047-2.605)were risk factors of NAFLD.Conclusions:Higher transaminase value is valuable for early diagnosing of NAFLD,which is helpful to prevent the development of NAFLD.
作者 张宇恒 丁素英 ZHANG Yuheng;DING Suying(The Physical Examination Center,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052)
出处 《郑州大学学报(医学版)》 CAS 北大核心 2019年第6期916-918,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关计划项目(22170050)
关键词 转氨酶 非酒精性脂肪肝 transaminase non-alcoholic fatty liver disease
  • 相关文献

参考文献3

二级参考文献71

  • 1范建高.中国非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中国医学前沿杂志(电子版),2012,4(7):4-10. 被引量:275
  • 2许宗凡,钟华,邹双凤.健康体检脂肪肝相关因素分析[J].中国药物经济学,2013,8(S3):417-418. 被引量:2
  • 3胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 4Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 5Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 6Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 7Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 8Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 9Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 10Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.

共引文献1832

同被引文献166

引证文献16

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部